BJL
VRTX icon

Brighton Jones LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Brighton Jones LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4M Buy
8,048
+1,292
+19% +$573K 0.07% 178
2026
Q1 		$3.02M Buy
+6,756
New +$3.15M 0.07% 206
2025
Q4 		– Sell
-4,693
Closed -$1.84M – 943
2025
Q3 		$1.84M Buy
4,693
+134
+3% +$56K 0.04% 237
2025
Q2 		$2.03M Sell
4,559
-1,862
-29% -$858K 0.06% 190
2025
Q1 		$3.11M Buy
6,421
+1,994
+45% +$929K 0.1% 119
2024
Q4 		$1.78M Buy
4,427
+579
+15% +$268K 0.05% 181
2024
Q3 		$1.79M Sell
3,848
-452
-11% -$217K 0.07% 144
2024
Q2 		$2.02M Buy
4,300
+3,171
+281% +$1.38M 0.07% 150
2024
Q1 		$472K Buy
1,129
+194
+21% +$82K 0.02% 360
2023
Q4 		$380K Sell
935
-129
-12% -$47.7K 0.02% 387
2023
Q3 		$370K Buy
1,064
+45
+4% +$15.7K 0.02% 353
2023
Q2 		$359K Buy
1,019
+60
+6% +$20.2K 0.02% 363
2023
Q1 		$302K Buy
959
+85
+10% +$25.5K 0.02% 375
2022
Q4 		$252K Sell
874
-369
-30% -$112K 0.02% 381
2022
Q3 		$360K Buy
1,243
+369
+42% +$106K 0.02% 300
2022
Q2 		$246K Buy
874
+29
+3% +$7.76K 0.01% 374
2022
Q1 		$221K Buy
+845
New +$201K 0.01% 454

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brighton Jones LLC's VRTX Position: Q2 2026 in Review

Brighton Jones LLC increased its Vertex Pharmaceuticals (VRTX) stake by 19% in Q2 2026, buying an estimated $573K and bringing the position to 8,048 shares worth $4M. The position accounts for 0.07% of the portfolio, ranked #178.

Brighton Jones LLC first reported a position in VRTX in Q1 2022 and has held it in 17 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Brighton Jones LLC held 8,048 shares of Vertex Pharmaceuticals worth $4M as of Q2 2026.
  • Brighton Jones LLC bought 1,292 Vertex Pharmaceuticals shares in Q2 2026, an estimated $573K.
  • Vertex Pharmaceuticals made up 0.07% of Brighton Jones LLC's portfolio in Q2 2026, its #178 holding.
  • Brighton Jones LLC first reported a position in Vertex Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
  • 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.